Recently, Zhou et al. (195) performed the first-in-human evaluation of [68Ga]Ga-NOTA-WL-12 in patients with NSCLC and demonstrated its safety and feasibility to be used as a companion diagnostic to quantify PD-L1 expression. The gene discussed is CD274; the disease is non-small cell lung carcinoma.